Literature DB >> 24700126

Bim regulates alloimmune-mediated vascular injury through effects on T-cell activation and death.

Anna von Rossum1, Winnie Enns1, Yu P Shi1, Grace E MacEwan1, Mehrnoush Malekesmaeli1, Ryan Brinkman1, Jonathan C Choy2.   

Abstract

OBJECTIVE: Bim is a proapoptotic Bcl-2 protein known to downregulate immune responses and to also be required for antigen-induced T-cell activation. However, it is not known how the effect of Bim on these offsetting processes determines the outcome of allogeneic immune responses. We have defined the role of Bim in regulating alloantigen-driven T-cell responses in a model of vascular rejection. APPROACH AND
RESULTS: Bim was required for proliferation of CD4 and CD8 T cells, and for interleukin-2 production, in T cells stimulated with alloantigen in vitro. Moreover, a partial reduction in Bim expression was sufficient to attenuate T-cell activation, whereas a complete elimination of Bim was required to prevent CD4 T-cell death in response to cytokine withdrawl. When alloimmune-mediated vascular rejection was examined using an aortic interposition model, there was significantly less intimal thickening in Bim(+/-), but not Bim(-/-), graft recipients. T-cell proliferation in response to allograft arteries was significantly reduced in both Bim(+/-) and Bim(-/-) mice, but cell death was attenuated only in Bim(-/-) animals.
CONCLUSIONS: Bim controls both T-cell activation and death in response to alloantigen stimulation. These processes act cooperatively to determine the outcome of immune responses in allograft arteries.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  Bim protein; T-cell; transplantation; vascular system injuries

Mesh:

Substances:

Year:  2014        PMID: 24700126      PMCID: PMC4097606          DOI: 10.1161/ATVBAHA.114.303649

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  42 in total

1.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

Authors:  P Bouillet; D Metcalf; D C Huang; D M Tarlinton; T W Kay; F Köntgen; J M Adams; A Strasser
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

2.  Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

Authors:  A D Wells; X C Li; Y Li; M C Walsh; X X Zheng; Z Wu; G Nuñez; A Tang; M Sayegh; W W Hancock; T B Strom; L A Turka
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.

Authors:  David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Mario C Deng; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

4.  Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.

Authors:  Charles P Sevigny; Li Li; Alaa S Awad; Liping Huang; Marcia McDuffie; Joel Linden; Peter I Lobo; Mark D Okusa
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 5.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

6.  Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Authors:  Elina Minami; Michael A Laflamme; Jeffrey E Saffitz; Charles E Murry
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

7.  Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells.

Authors:  Yifan Zhan; Yuxia Zhang; Daniel Gray; Emma M Carrington; Philippe Bouillet; Hyun-Ja Ko; Lorraine O'Reilly; Ian P Wicks; Andreas Strasser; Andrew M Lew
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

Review 8.  Cytokines and transplantation: a clinical perspective.

Authors:  R S Gaston
Journal:  Transplant Sci       Date:  1994-12

9.  Risk factors for chronic rejection in renal allograft recipients.

Authors:  P S Almond; A Matas; K Gillingham; D L Dunn; W D Payne; P Gores; R Gruessner; J S Najarian
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

10.  Cytokine-mediated programmed proliferation of virus-specific CD8(+) memory T cells.

Authors:  Hans-Peter Raué; Carol Beadling; Jennifer Haun; Mark K Slifka
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

View more
  2 in total

1.  Mouse model of alloimmune-induced vascular rejection and transplant arteriosclerosis.

Authors:  Winnie Enns; Anna von Rossum; Jonathan Choy
Journal:  J Vis Exp       Date:  2015-05-17       Impact factor: 1.355

2.  Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.

Authors:  Kevin Rey; Sukhbir Manku; Winnie Enns; Thea Van Rossum; Kevin Bushell; Ryan D Morin; Fiona S L Brinkman; Jonathan C Choy
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.